NET PROFIT (x1000 NOK)
EMPLOYEES
Biomedrex AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
126
|
200
|
200 |
| Earnings before taxes |
319
|
380
|
-805 |
| EBITDA |
443
|
575
|
-605 |
| Total assets |
17,237
|
15,817
|
14,439 |
| Current assets |
46
|
197
|
1,039 |
| Current liabilities |
3,875
|
3,731
|
3,061 |
| Equity capital |
5,036
|
4,657
|
3,993 |
| - share capital |
50
|
50
|
48 |
| Employees (average) |
3
|
3
|
8 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
29.2%
|
29.4%
|
27.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
2.6%
|
3.7%
|
-4.2% |
| Current ratio |
1.2%
|
5.3%
|
33.9% |
| Return on equity (ROE) |
6.3%
|
8.2%
|
-20.2% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
-5
|
4 |
| Chg. No. of employees % |
0%
|
-63%
|
100% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.